Pace Ventures focuses on investing in early-stage health-tech and industrial-tech companies primarily in Europe and the US, with a focus on companies addressing the interconnected challenges of illness and climate change. They commit to providing strong support to their founders, particularly in making commercial and financial introductions. They view investments as long-term partnerships, emphasizing time and effort to ensure success. The firm prioritizes category-defining businesses with a strong technological or life science edge. Pace Ventures believes that the private sector is best positioned to drive innovation in green chemistry and material science to reduce dependence on fossil fuels. They observe a growing number of startups in the green chemistry space and anticipate rapid adoption of these new green materials by the chemical industry. They also invest in microbiome-based therapies and personalized medicine. The fund aims to back companies that are reshaping industries with their innovative approaches, contributing to a healthier and more sustainable future. Their investment strategy reflects a belief in proactive support and a commitment to creating lasting value alongside their portfolio companies.
Preferred startup development maturity for initial funding deployment.
health-tech, industrial-tech, green chemistry, bio-based materials, microbiome, AI, life science
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...